Option Care Health (DE:MM6A)
FRANKFURT:MM6A
MM6A Stock Chart & Stats
€22.40
€0.00(0.00%)
At close: 4:00 PM EST
€22.40
€0.00(0.00%)
Day’s Range― - ―
52-Week Range€22.20 - €31.80
Previous CloseN/A
Volume0.00
Average Volume (3M)3.00
Market Cap
€3.73B
Enterprise Value€4.13B
Total Cash (Recent Filing)€232.62M
Total Debt (Recent Filing)€0.00
Price to Earnings (P/E)24.3
Beta0.52
Next Earnings
Apr 29, 2026EPS Estimate
0.33Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.40
Shares Outstanding156,447,970
10 Day Avg. Volume0
30 Day Avg. Volume3
Financial Highlights & Ratios
PEG Ratio5.98
Price to Book (P/B)3.80
Price to Sales (P/S)0.89
P/FCF Ratio19.51
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€34.70Price Target Upside54.93% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering12
EPS Forecast (FY)1.61
Revenue Forecast (FY)€5.12B
Bulls Say, Bears Say
Bulls Say
Capital Allocation And BuybacksBoard approved a sizable increase in share repurchase authorization, reinforcing focus on shareholder returns and providing potential EPS support as cash generation improves.
Guidance And Cash FlowManagement affirmed prior guidance and expects a meaningful increase in cash flow from operations, supporting internal investments and resilience in funding growth initiatives.
Portfolio DiversificationCompany disclosed that no single therapy represents a dominant share of gross profit and reduced reliance on one drug, materially lowering concentration risk and enabling steadier revenue recovery.
Bears Say
Inventory Unwind And Comparable PressureUnwinding of prior inventory-driven sales boosts will produce tougher year-over-year comparisons and could result in softer reported growth in upcoming quarters.
Margin Compression From Expense And Mix ShiftsOperating expenses are expected to grow in line with or faster than gross profit while therapy and payer mix shifts pressure margins, limiting potential margin expansion.
Stelara And Biosimilar HeadwindsStelara-related pricing pressure and the emergence of biosimilars are expected to reduce revenue and gross profit, creating a material headwind to near-term results.
Option Care Health News
MM6A FAQ
What was Option Care Health’s price range in the past 12 months?
Option Care Health lowest stock price was €22.20 and its highest was €31.80 in the past 12 months.
What is Option Care Health’s market cap?
Option Care Health’s market cap is €3.73B.
When is Option Care Health’s upcoming earnings report date?
Option Care Health’s upcoming earnings report date is Apr 29, 2026 which is in 23 days.
How were Option Care Health’s earnings last quarter?
Option Care Health released its earnings results on Feb 24, 2026. The company reported €0.4 earnings per share for the quarter, missing the consensus estimate of €0.407 by -€0.008.
Is Option Care Health overvalued?
According to Wall Street analysts Option Care Health’s price is currently Undervalued.
Does Option Care Health pay dividends?
Option Care Health does not currently pay dividends.
What is Option Care Health’s EPS estimate?
Option Care Health’s EPS estimate is 0.33.
How many shares outstanding does Option Care Health have?
Option Care Health has 156,447,970 shares outstanding.
What happened to Option Care Health’s price movement after its last earnings report?
Option Care Health reported an EPS of €0.4 in its last earnings report, missing expectations of €0.407. Following the earnings report the stock price went up 1.351%.
Which hedge fund is a major shareholder of Option Care Health?
Currently, no hedge funds are holding shares in DE:MM6A
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Option Care Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€34.70 (54.93% Upside)
€34.70 (54.93% Upside)
Blogger Sentiment
Bullish
DE:MM6A Sentiment 66%
Sector Average 70%
Sector Average 70%
Insider Transactions
Sold Shares
Worth $1.2M over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-21.04%
12-Months-Change
Fundamentals
Return on Equity
15.39%
Trailing 12-Months
Asset Growth
0.81%
Trailing 12-Months
Company Description
Option Care Health
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; infusion therapies for bleeding disorders; therapies that women need to survive and thrive through high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.
MM6A Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveys a constructive operational and financial story: strong top-line growth, margin and automation gains, successful clinic and M&A integration, expanded pharma and payer partnerships, and a reaffirmation of 2026 guidance. Key near-term challenges include Stelara biosimilar-driven revenue and gross profit headwinds, a 2025 cash flow shortfall due to strategic inventory buys and elevated working capital needs, and persistent payer/market pressure. Management outlined concrete efficiency and cash-conversion actions and expects cash flow and EBITDA expansion in 2026, indicating confidence that headwinds are manageable.View all DE:MM6A earnings summariesMM6A Stock 12 Month Forecast
Average Price Target
€34.70
▲(54.93% Upside)
Technical Analysis
Addus Homecare
―
Chemed
―
National Healthcare
―
Surgery Partners
―
Aveanna Healthcare Holdings
―
Options Prices
Currently, No data available
---